HLVX Insider Trading
Insider Ownership Percentage: 71.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $193,765.70
HilleVax Share Price & Price History
Current Price: $1.42
Price Change: ▼ Price Decrease of -0.03 (-2.07%)
As of 04/4/2025 05:00 PM ET
HilleVax Insider Trading History
HilleVax Institutional Trading History
Data available starting January 2016
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Read More on HilleVax
Volume
665,777 shs
Average Volume
434,993 shs
Market Capitalization
$71.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Who are the company insiders with the largest holdings of HilleVax?
HilleVax's top insider shareholders include:
- Life Sciences X LP Frazier (Major Shareholder)
- Robert Hershberg (Insider)
- Aditya Kohli (Director)
- Astrid Borkowski (Insider)
- Shane Maltbie (CFO)
- Sean Mcloughlin (COO)
Learn More about top insider investors at HilleVax.